ATE88572T1 - Antikoerper gegen polypeptide, die gegen peptide oder proteine mit mindestens teilweise bekannter aminosaeure oder kodierender nukleotidsequenz komplementaer sind und diesbezuegliches aufbauverfahren. - Google Patents

Antikoerper gegen polypeptide, die gegen peptide oder proteine mit mindestens teilweise bekannter aminosaeure oder kodierender nukleotidsequenz komplementaer sind und diesbezuegliches aufbauverfahren.

Info

Publication number
ATE88572T1
ATE88572T1 AT89106162T AT89106162T ATE88572T1 AT E88572 T1 ATE88572 T1 AT E88572T1 AT 89106162 T AT89106162 T AT 89106162T AT 89106162 T AT89106162 T AT 89106162T AT E88572 T1 ATE88572 T1 AT E88572T1
Authority
AT
Austria
Prior art keywords
peptides
antibodies
proteins
amino acid
production
Prior art date
Application number
AT89106162T
Other languages
English (en)
Inventor
Edwin J Blalock
Kenneth L Bost
Eric M Smith
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/708,001 external-priority patent/US4863857A/en
Application filed by Univ Texas filed Critical Univ Texas
Application granted granted Critical
Publication of ATE88572T1 publication Critical patent/ATE88572T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/803—Physical recovery methods, e.g. chromatography, grinding
AT89106162T 1985-03-01 1986-02-24 Antikoerper gegen polypeptide, die gegen peptide oder proteine mit mindestens teilweise bekannter aminosaeure oder kodierender nukleotidsequenz komplementaer sind und diesbezuegliches aufbauverfahren. ATE88572T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/708,001 US4863857A (en) 1985-03-01 1985-03-01 Polypeptide complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known
US06/829,709 US5077195A (en) 1985-03-01 1986-02-19 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor
EP86901662A EP0214232B1 (de) 1985-03-01 1986-02-24 Komplementäre polypeptide gegen peptide oder proteine mit mindestens teilweise bekannter aminosäure- oder nukleotidkodierender sequenz und diesbezügliches aufbauverfahren
EP89106162A EP0332225B1 (de) 1985-03-01 1986-02-24 Antikörper gegen Polypeptide, die gegen Peptide oder Proteine mit mindestens teilweise bekannter Aminosäure oder kodierender Nukleotidsequenz komplementär sind und diesbezügliches Aufbauverfahren

Publications (1)

Publication Number Publication Date
ATE88572T1 true ATE88572T1 (de) 1993-05-15

Family

ID=27108003

Family Applications (2)

Application Number Title Priority Date Filing Date
AT86901662T ATE63138T1 (de) 1985-03-01 1986-02-24 Komplementaere polypeptide gegen peptide oder proteine mit mindestens teilweise bekannter aminosaeure- oder nukleotidkodierender sequenz und diesbezuegliches aufbauverfahren.
AT89106162T ATE88572T1 (de) 1985-03-01 1986-02-24 Antikoerper gegen polypeptide, die gegen peptide oder proteine mit mindestens teilweise bekannter aminosaeure oder kodierender nukleotidsequenz komplementaer sind und diesbezuegliches aufbauverfahren.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT86901662T ATE63138T1 (de) 1985-03-01 1986-02-24 Komplementaere polypeptide gegen peptide oder proteine mit mindestens teilweise bekannter aminosaeure- oder nukleotidkodierender sequenz und diesbezuegliches aufbauverfahren.

Country Status (18)

Country Link
US (2) US5077195A (de)
EP (2) EP0332225B1 (de)
JP (1) JPH07215999A (de)
KR (1) KR920002315B1 (de)
AT (2) ATE63138T1 (de)
AU (1) AU592781B2 (de)
BR (1) BR8606615A (de)
CA (1) CA1339606C (de)
DE (2) DE3679017D1 (de)
DK (1) DK521386A (de)
ES (3) ES8705919A1 (de)
FI (1) FI90255C (de)
GR (1) GR860576B (de)
IE (1) IE58837B1 (de)
IL (1) IL96043A0 (de)
NO (1) NO174971C (de)
PT (1) PT82132B (de)
WO (1) WO1986005208A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986002666A1 (en) * 1984-10-29 1986-05-09 Microgenics Corporation Methods for protein binding enzyme complementation assays
DE3527568A1 (de) * 1985-08-01 1987-02-05 Bissendorf Peptide Gmbh Synthetische peptidrezeptoren, verfahren zur herstellung und verwendung derselben
CA1297003C (en) * 1985-09-20 1992-03-10 Jack H. Nunberg Composition and method for treating animals
AU595597B2 (en) * 1986-02-19 1990-04-05 Triton Biosciences Inc. Peptides affecting blood pressure regulation
US4772684A (en) * 1987-01-20 1988-09-20 Triton Biosciences, Inc. Peptides affecting blood pressure regulation
DK105289A (da) * 1988-03-04 1989-09-05 Univ Alabama Peptidaekvivalenter til ikke-peptider og fremgangsmaader til udformning af disse
EP0411503B1 (de) * 1989-07-31 1999-12-15 TECNOGEN Società Consortile per azioni Verfahren zur Identifizierung und Herstellung von Bindungsstellen aufeinanderwirkender Proteine
US5324512A (en) * 1990-12-26 1994-06-28 The Population Council [Gln']-luteinizing hormone releasing hormone conjugate of tetanus vaccine and its uses
JPH05262788A (ja) * 1991-09-03 1993-10-12 Hitachi Chem Co Ltd ペプチド類、その設計方法及び製造方法並びに受容体上の生理活性ペプチドの結合部位の決定方法
US5620675A (en) * 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
US6017512A (en) * 1992-06-23 2000-01-25 Diatide, Inc. Radiolabeled peptides
EP0672421B1 (de) * 1993-10-07 2002-03-20 Kurashiki Boseki Kabushiki Kaisha Hemmer der aktivität von endothelin
US6051206A (en) * 1994-06-03 2000-04-18 Diatide, Inc Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
IL115177A0 (en) * 1994-09-16 1995-12-31 Immunomedics Inc Phosphorus-32 labeling of antibodies for cancer therapy
US5523208A (en) * 1994-11-30 1996-06-04 The Board Of Trustees Of The University Of Kentucky Method to discover genetic coding regions for complementary interacting proteins by scanning DNA sequence data banks
DE69627333T2 (de) 1995-06-26 2004-02-12 PerSeptive Biosystems, Inc., Framingham Automatisierte, kontinuierliche mehrdimensionale hochgeschwindigkeitsmolekularselektion und -analyse
US5807552A (en) * 1995-08-04 1998-09-15 Board Of Regents, The University Of Texas System Compositions for conferring immunogenicity to a substance and uses thereof
CA2313028A1 (en) * 1997-12-01 1999-06-10 Cfy Biomedicals, Inc. Multivalent recombinant antibodies for treating hrv infections
DE19805334A1 (de) * 1998-02-11 1999-08-12 Otogene Biotechnologische Fors Verfahren zur Entwicklung eines pharmazeutischen Wirkstoffes
AU762711C (en) * 1998-04-24 2004-05-27 Fang Fang Identifying peptide ligands of target proteins with target complementary library technology (TCLT)
US20030035798A1 (en) * 2000-08-16 2003-02-20 Fang Fang Humanized antibodies
WO2000053621A2 (en) * 1999-03-09 2000-09-14 Jeffrey Lynn Haddox Synthetic complementary peptides and ophthalmologic uses thereof
GB2356401A (en) * 1999-11-19 2001-05-23 Proteom Ltd Method for manipulating protein or DNA sequence data
GB9929469D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligands generated from plant genomes
GB9929464D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligande generated from the human genome
GB9929466D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligands generated from microbial genome sequences
WO2002027313A1 (en) * 2000-09-26 2002-04-04 Geneformatics, Inc. Methods for determining aproximations of three dimensional polypeptide structure
GB0025251D0 (en) * 2000-10-14 2000-11-29 Proteom Ltd Antisense peptides to Fc receptors and their uses
ATE488576T1 (de) * 2001-02-20 2010-12-15 Univ Georgia Schnellproduktion monoklonaler antikörper
EP1578917A4 (de) 2001-07-19 2008-01-23 Perlan Therapeutics Inc Multimere proteine und verfahren zu deren herstellung und verwendung
US8227583B2 (en) * 2007-06-14 2012-07-24 The Board Of Regents For Oklahoma State University Vaccines containing canine parvovirus genetic variants
CN101815528A (zh) * 2007-06-14 2010-08-25 俄克拉荷马州大学评议会 包含犬细小病毒遗传性变体的疫苗
US20190062373A1 (en) * 2017-08-30 2019-02-28 Peption, LLC Method of generating interacting peptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes

Also Published As

Publication number Publication date
NO864369D0 (no) 1986-10-31
EP0214232B1 (de) 1991-05-02
NO174971B (no) 1994-05-02
DE3688333D1 (de) 1993-05-27
GR860576B (en) 1986-07-01
ES8800267A1 (es) 1987-11-01
AU592781B2 (en) 1990-01-25
CA1339606C (en) 1997-12-30
JPH07215999A (ja) 1995-08-15
DE3688333T2 (de) 1993-10-28
ES8705919A1 (es) 1987-05-16
NO174971C (no) 1994-08-10
KR920002315B1 (ko) 1992-03-21
ES552534A0 (es) 1987-05-16
EP0332225B1 (de) 1993-04-21
IL96043A0 (en) 1991-07-18
IE860527L (en) 1986-09-01
DK521386A (da) 1986-12-29
EP0332225A3 (en) 1989-09-27
FI90255C (fi) 1994-01-10
DE3679017D1 (de) 1991-06-06
BR8606615A (pt) 1987-08-11
PT82132B (pt) 1989-05-31
US5077195A (en) 1991-12-31
ATE63138T1 (de) 1991-05-15
ES8800266A1 (es) 1987-11-01
ES557188A0 (es) 1987-11-01
FI864427A (fi) 1986-10-30
DK521386D0 (da) 1986-10-31
EP0332225A2 (de) 1989-09-13
ES557189A0 (es) 1987-11-01
US5212072A (en) 1993-05-18
FI864427A0 (fi) 1986-10-30
KR870700100A (ko) 1987-02-28
EP0214232A1 (de) 1987-03-18
NO864369L (no) 1987-01-02
WO1986005208A1 (en) 1986-09-12
AU5510286A (en) 1986-09-24
IE58837B1 (en) 1993-11-17
FI90255B (fi) 1993-09-30
PT82132A (en) 1986-04-01

Similar Documents

Publication Publication Date Title
ATE88572T1 (de) Antikoerper gegen polypeptide, die gegen peptide oder proteine mit mindestens teilweise bekannter aminosaeure oder kodierender nukleotidsequenz komplementaer sind und diesbezuegliches aufbauverfahren.
PT87138A (pt) Process for the preparation of adn recombinant molecules codin g polypeptide adn segments and of antibody compositions relate d with human tissue factor
DE3855536T2 (de) Rezeptoren für wachstumshormone
ATE50458T1 (de) Bestimmung von fibrin mit fibrin-spezifischen antikoerpern.
ATE133993T1 (de) Protein-antikrebsmittel
ES2109225T3 (es) Anticuerpos, su produccion y uso.
KR890012669A (ko) 심방 나트륨이뇨성 폴리펩티드를 인지하는 단일클론성 항체

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties